Long Term Survival and Quality of Life Following Transcatheter Aortic Valve Replacement in Nonagenarians.

Document Type

Article

Publication Date

12-20-2023

Publication Title

The American journal of cardiology

Abstract

Transcatheter aortic valve replacement (TAVR) has emerged as a successful treatment option for severe aortic stenosis (AS). However, the long term outcomes of TAVR in nonagenarians is lacking. We aimed to examine the long-term mortality and quality-of-life in nonagenarians after TAVR. This is a multi-center retrospective analysis on patients with severe AS undergoing TAVR. Patients were divided into two groups: Nonagenarians (age ≥ 90 years) and age < 90 years. Kansas city cardiomyopathy questionnaires (KCCQ) and New York Heart Associated (NYHA) scores were compared pre- and post-TAVR. All-cause mortality was compared between both groups at 30 days, 1-year and 5-years post-TAVR using Cox-proportional hazard model. A total of 6896 patients were included, of which 591 were nonagenarians. Nonagenarians had a higher STS perioperative risk of mortality (8.1 ± 4.6% vs 5.4 ± 4.2%, p

Volume

S0002-9149

Issue

23

First Page

01415-7

DOI

10.1016/j.amjcard.2023.12.031

ISSN

1879-1913

PubMed ID

38134979

Share

COinS